Negotiating with Centers for Medicare and Medicaid Services: A Scenario Planning Framework

In September, the first 10 products were identified for negotiation with Centers for Medicare and Medicaid Services. Some pharmaceutical companies are waiting to see how the litigation plays out, while others are preparing to negotiate based on assumptions about the final process. Any number of outcomes are possible, and planning for a set of the most likely scenarios will allow companies to identify accompanying strategies and tactics – and be prepared to act up against a potentially tight timeline.